Labs are getting smaller, more automated, and more distributed. Instruments are shrinking and handling more of the manual work themselves. Research hubs outside the traditional life science centers are standing up modular, flexible labs instead of building large centralized infrastructure. And right alongside that shift, suppliers are moving toward reagent rental agreements, consumable subscriptions, and SaaS-based informatics billing instead of one-time sales.
That’s three changes happening at once: what your customers buy, where they’re located, and how they want to pay for it. Most reagent, kit, and instrument companies have updated their product line to keep up with the first one. Far fewer have updated their pricing, their CRM, or how they measure success to keep up with the third.
If your sales team is still chasing new-deal count as the primary metric, you’re measuring a business model your own market is leaving behind.
Why this shows up first in your reporting, not your revenue
A subscription or standing-order model doesn’t show up as a problem in month one. It shows up six months later, when a sales rep who’s used to closing one-time deals can’t explain why this quarter’s new bookings look smaller, even though net revenue retention is actually up. If your dashboards don’t track retention and reorder rate as clearly as new-deal volume, you’ll make the wrong call based on the wrong number.
PSG Life Sciences works across the laboratory supplies, automation, and workflow technologies market, liquid handling and sample prep systems, automated workflows and robotics, magnetic bead-based purification kits, and the LIMS and ELN platforms tying it all together. We’ve watched this shift happen inside client businesses, and we know exactly which CRM fields and pricing structures need to change first.
Where PSG Life Sciences fits
Need a product line and pricing structure that fits decentralized, modular labs, not just established research centers? Our Start solution builds entry-level and mid-tier positioning for this growing buyer segment, instead of forcing every prospect into your flagship pricing.
Ready to shift from one-time sales to subscription, standing order, or rental revenue? Our Grow solution rebuilds your pricing model, CRM tracking, and sales incentives around recurring revenue, so your team is rewarded for retention, not just new logos.
Need dashboards that actually show net revenue retention, not just new bookings? HubSpot Life Sciences Pro configures reporting around the metrics that matter in a recurring-revenue business.
What we actually build for automation and decentralized-lab companies
- Pricing models built around reagent rental, consumable subscriptions, or standing orders where the market is already moving that direction
- Product and pricing tiers sized for decentralized and modular labs, not only large established research centers
- CRM dashboards that prioritize net revenue retention alongside new deal volume, so leadership sees the real health of the business
- Automation-compatibility positioning, since a kit built only for manual pipetting is a harder sell into a lab that’s already automated its core workflow
- Distributor evaluation for reaching geographically dispersed decentralized labs more efficiently than direct sales alone
A direct question worth asking yourself
If a board member asked for your net revenue retention number right now, would you have it ready, or would you have to go pull new-deal bookings instead because that’s the number your CRM actually tracks well?
Ready to rebuild your commercial model around recurring revenue?
PSG Life Sciences is a HubSpot Gold partner and fractional commercialization firm working exclusively with biotech, life science, and diagnostic product companies, including the lab automation and workflow technologies this shift is built on. We build the pricing, CRM, and reporting systems described above as implemented client work, not theory.